CRL
Charles River Laboratories International, Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$288.87
−1.53%Leverage
- Debt / equity
- 1.07x
- Net debt / equity
- 1.00x
- Debt / assets
- 0.40x
- Debt / EBITDA
- 13.73x
- Net debt / EBITDA
- 12.86x
Liquidity & coverage
- Current ratio
- 1.35x
- Quick ratio
- 1.04x
- Cash ratio
- 0.17x
- Interest coverage
- 4.65x
- EBITDA / interest
- 2.07x
- Working capital
- $394.4M
Cash & dividend
- FCF / debt
- 0.12x
- Cash flow / debt
- 0.19x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026